Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Professor of Medicine and Associate Dean for Clinical Research
Emory University School of Medicine

Vice Chair for Grady Affairs, Department of Medicine
Atlanta, Georgia

Topics of Professional Interest:

Adherence to ART

Current Professional Summary:

Dr Jeffrey Lennox is Professor of Medicine, Emory University School of Medicine in Atlanta, Georgia. He is Associate Dean for Clinical Research at Emory and the Vice-Chair of Medicine for Grady affairs. He is the Co-PI for the Emory-CDC HIV Clinical Trials Unit, and co-Director of the Clinical Core of the Emory Center for AIDS Research. For 15 years Dr Lennox was also the Medical Director of the infectious disease program at the Grady Ponce de Leon Center, one of the largest HIV care clinics in the country.    

Committees and Organizations:

DHHS Antiretroviral therapy guidelines panel

Honors and Awards:

HIVMA Clinician Educator of the Year, 2008

Education:

B.A., Molecular, Cellular and Developmental Biology, 1975-1979

University of Colorado, Boulder, Colorado

 M.D, 1979-1983

University of Colorado School of Medicine, Denver, Colorado

Selected Publications:

Lennox, JL,  DeJesus E, Ramalho Madruga JV, Lazzarin A, Pollard RB, Berger DS, Zhao J, Xu X,  Williams-Diaz A, Rodgers AJ, Barnard RJO,  Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P.  Safety and Efficacy of Raltegravir-based versus Efavirenz-based Combination Therapy in Treatment-Naive HIV-1 Infected Patients, Lancet, 2009, 374: 796-806

Lennox, JL,  DeJesus E, Berger DS, Lazzarin A, Pollard RB, Ramalho Madruga JV, Zhao J, Wan H,  Gilbert CL, B.S.7, Teppler H, Rodgers AJ, Barnard RJO,  Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P.  Raltegravir versus Efavirenz Regimens in Treatment-Naive HIV-1 Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses. J AIDS 2010, 55:39-48

Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na L, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn S, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS. Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial. Annals of Internal Medicine 2014, 161(7):461-471.